:

Medical Meetings

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Keywords:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 30-Apr-2016 12:00 AM EDT

Medicine

Channels:

Keywords:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 4-May-2016 1:15 PM EDT

Medicine

Channels:

Keywords:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 5-May-2016 12:45 PM EDT

Medicine

Channels:

Keywords:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 2-May-2016 8:30 PM EDT

Medicine

Channels:

Keywords:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 4-May-2016 1:15 PM EDT

Medicine

Channels:

Keywords:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 3-May-2016 3:45 PM EDT

Medicine

Channels:

Keywords:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 3-May-2016 7:45 PM EDT

Medicine

Channels:

Keywords:

Zika, Ebola, West Nile Experts and Humanitarians to Speak at Free Events

The Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) is the largest gathering of eye and vision researchers in the world, with over 11,000 attendees from more than 75 countries. Two free events will feature speakers highlighting recent successes — and emerging threats — facing ophthalmic clinicians and researchers around the world.

Medicine

Channels:

Keywords:

Media Invitation: Press Conference by Webcast

This ARVO Meeting showcases cutting-edge eye and vision science and an early glimpse into the latest advances in potential treatments for eye disease and blindness — often years ahead of their introduction to the clinic.

Medicine

Channels:

Keywords:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 4-May-2016 1:15 PM EDT

Medicine

Channels:

Keywords:

Addressing Sexual Health and Ensuring Safe Alternate Route Chemotherapy Administration in Cancer Patients

nurse_practionerwithsteth.jpg

The topic of sexual dysfunction may be a difficult one to discuss between healthcare providers and cancer patients. The nursing and social work teams at Rutgers Cancer Institute of New Jersey explored this issue in order to improve the conversation and ensure quality oncology care. Nurses also examined how to ensure the safety of alternate route chemotherapy administration. The work is being presented at the Oncology Nursing Society’s Annual Congress meeting this week in San Antonio.

Medicine

Channels:

Keywords:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 4-May-2016 11:00 AM EDT

Medicine

Channels:

Keywords:

Watercress Extract Detoxifies Carcinogens in Smokers, Clinical Trial Demonstrates

yuan-tobacco-detox-main_1.jpg

Watercress extract taken multiple times a day significantly inhibits the activation of a tobacco-derived carcinogen in cigarette smokers, researchers at the University of Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCenter, demonstrated in a phase II clinical trial presented today at the American Association for Cancer Research (AACR) Annual Meeting in New Orleans.

Medicine

Channels:

Keywords:

Ludwig’s Luis Diaz to Deliver Plenary at 2016 AACR Annual Meeting on Liquid Biopsies for the Early Detection of Cancer

Ludwig Cancer Research scientist Luis Diaz will be giving a plenary lecture today at the Annual Meeting of the American Association for Cancer Research in New Orleans. His talk, titled “Liquid biopsies and the early diagnosis of cancer,” will survey the scientific history and current state of efforts to develop minimally invasive diagnostic tests for the early detection of cancer. An oncologist who has long been at the forefront of this field, Diaz will focus on the technologies and strategies employed to capture and profile DNA shed by tumors.

Medicine

Channels:

Keywords:

Combination Therapy Incorporating 3 New Agents Shows Promise as Treatment for Aggressive Lymphoma

New research from Roswell Park Cancer Institute (RPCI) shows that promising cancer drugs used in combination can have significant therapeutic impact on a particularly aggressive subtype of diffuse large B-cell lymphoma (DH-DLBCL) in preclinical studies. The researchers will present their findings at the American Association for Cancer Research (AACR) Annual Meeting 2016, to be held April 16-20 in New Orleans.

Medicine

Channels:

Keywords:

Multivitamin Use Protects Against Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Patients

Researchers at Roswell Park Cancer Institute (RPCI), in collaboration with investigators from the cooperative group SWOG, have found that use of multivitamins prior to diagnosis may reduce the risk of neuropathy in breast cancer patients treated with the class of drugs known as taxanes. The team will present their findings at the American Association for Cancer Research (AACR) Annual Meeting 2016, to be held April 16-20 in New Orleans.

Medicine

Channels:

Keywords:

Scientists Identify Compounds that May Enhance Antitumor Activity of Vitamin D

Roswell Park Cancer Institute (RPCI) research on the most potent form of vitamin D, commonly called calcitriol, offers new insights into approaches that may enhance the antitumor activity of this much-studied human hormone. The researchers will share their findings in an oral presentation at the American Association for Cancer Research (AACR) Annual Meeting 2016, to be held April 16-20 in New Orleans.

Medicine

Channels:

Keywords:

Immunotherapy Drug Shrinks Tumors in Half of Patients with Rare, Virus-Linked Skin Cancer

MCC1.jpg

In a clinical trial of the immunotherapy drug pembrolizumab, half of 25 patients with a rare type of virus-linked skin cancer called Merkel cell carcinoma experienced substantial tumor shrinkage lasting nearly three times as long, on average, than with conventional chemotherapy.

Medicine

Channels:

Keywords:

Delaying Radiation Therapy for Women with Very Early Breast Cancer Ups Recurrence

Delaying radiation therapy too long after surgery significantly increases the risk of recurrent tumors in women treated for very early, or what is referred to as “stage 0,” breast cancer, according to new research at Washington University School of Medicine in St. Louis.

Medicine

Channels:

Keywords:

Precision Prevention of Colorectal Cancer

UlrikePeters_PHOTO_1.jpg

Precision medicine’s public face is that of disease — and better treatments for that disease through targeted therapies. But precision medicine has an unsung partner that could affect the lives of many more people: Precision prevention — a reflection of the growing realization that preventing cancer and other diseases may not be one-size-fits-all.